The Chinese government is to step up scrutiny of the cost effectiveness of its medical treatments, under a new technical co-operation agreement signed with the UK’s drug advisory body.
根据与英国医药咨询机构新签署的一项技术合作协议，manbetx3.0 政府将加强对国内医疗情况成本效率的审核。
您已阅读11%（230字），剩余89%（1827字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。